Samuel Oschin Comprehensive Cancer Inst. — Los Angeles, California

Samuel Oschin Comprehensive Cancer Inst. is a clinical research site located in Los Angeles, California, United States 90048.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Samuel Oschin Comprehensive Cancer Inst. has participated in 1 clinical trials.

Therapeutic areas: Renal Cell Carcinoma.

Sponsors: Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Samuel Oschin Comprehensive Cancer Inst.?

Samuel Oschin Comprehensive Cancer Inst. has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Samuel Oschin Comprehensive Cancer Inst. conducted?

Samuel Oschin Comprehensive Cancer Inst. has 1 clinical trials on record. Their work covers Renal Cell Carcinoma.

Is Samuel Oschin Comprehensive Cancer Inst. accredited by Crixeo Health?

Samuel Oschin Comprehensive Cancer Inst. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Samuel Oschin Comprehensive Cancer Inst.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.